Transient Receptor Potential (TRP) channels constitute a somewhat eclectic family of ion channels that share structural similarities and some functional properties, especially cation permeability and weak voltage sensitivity. TRP channels are expressed in virtually every cell type present in the heart, including cardiomyocytes, fibroblasts, endothelial cells and vascular smooth muscle cells 1 .
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Thus, the response of Trpv2 -/-neurons to either of these compounds was not distinguishable from WT neurons 4 . Likewise, inhibitors of TRPV2 include promiscuous compounds such as SKF96365, amiloride, ruthenium red, trivalent cations and citral. Recently, Tranilast has emerged as a TRPV2 specific blocker although its clear that this compound also affects other targets (see below) 3 .
An important theme in the understanding of the cellular role of TRPV2 is the subcellular localization of the channel protein and the trafficking from internal cytosolic pools towards the plasma membrane. TRPV2 was originally cloned as a calcium-permeable channel that, when overexpressed in a cell line, translocates to the plasma-membrane in response to insulin-like-growth factor 1 5 . In cultured and primary ß-cells TRPV2 expression at the plasma membrane is increased by insulin, after binding to the insulin receptor and activation of PI3 kinase 6 .
In the heart muscle, TRPV2 was proposed to be responsible for the positive inotropic effect of probenecid, which has no effect on cardiac contractility in 
